[AKRO] YoY Quarter Result on 30-Jun-2021 [#Q2]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
13-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -91.74%
YoY- -78.52%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -55,987 -31,083 -27,403 -28,933 -16,207 -7,228 -8,673 36.41%
Tax 0 6,260 297 -50 -1,323 -7,609 -8,662 -
NP -55,987 -31,083 -27,403 -28,933 -16,207 -7,228 -8,673 36.41%
Tax Rate - - - - - - - -
Total Cost 55,987 31,083 27,403 28,933 16,207 7,228 8,673 36.41%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.81 -0.60 -0.77 -0.83 -0.57 -2.21 -0.41 12.00%
EPS Diluted -0.81 -0.60 -0.77 -0.83 -0.57 -2.21 -0.41 12.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.